Metabolomics platforms for genome wide association studies-linking the genome to the metabolome

Current Opinion in Biotechnology

Volumn 24, Issue 1, 2013, Pages 39-47

  Adamski, Jerzy ^a,b,c   Suhre, Karsten ^a,d  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^d WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CONCENTRATIONS; GENETIC FACTORS; GENETIC VARIANCE; GENOME-WIDE ASSOCIATION; HIGH-THROUGHPUT SCREENING; METABOLOMES; METABOLOMICS; SECONDARY METABOLITES; SIGNAL MOLECULES;

AMINO ACIDS; CARBOHYDRATES; DIAGNOSIS;

GENES;

FLOW INJECTION ANALYSIS; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; HIGH THROUGHPUT SCREENING; HOMOZYGOTE; HUMAN; LIPIDOMICS; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TANDEM MASS SPECTROMETRY;

COHORT STUDIES; ENVIRONMENT; GENOME; GENOME-WIDE ASSOCIATION STUDY; HUMANS; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; METABOLOMICS; PHENOTYPE;

EID: 84872274119     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2012.10.003     Document Type: Review

References (50)

1. Hyotylainen T. Novel methodologies in metabolic profiling with a focus on molecular diagnostic applications. Expert Rev Mol Diagn 2012, 12:527-538.
2. Vizán P., Mazurek S., Cascante M. Robust metabolic adaptation underlying tumor progression. Metabolomics 2008, 4:1-12.
3. Mootha V.K., Hirschhorn J.N. Inborn variation in metabolism. Nat Genet 2010, 42:97-98.
4. Weiss R.H., Kim K. Metabolomics in the study of kidney diseases. Nat Rev Nephrol 2011, 8:22-33.
5. Rhee E.P., Gerszten R.E. Metabolomics and cardiovascular biomarker discovery. Clin Chem 2012, 58:139-147.
6. Dunn W.B., Broadhurst D.I., Atherton H.J., Goodacre R., Griffin J.L. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev 2011, 40:387-426.
7. Koal T., Deigner H.P. Challenges in mass spectrometry based targeted metabolomics. Curr Mol Med 2010, 10:216-226.
8. Artati A., Prehn C., Möller G., Adamski J. Assay tools for metabolomics. Genetics Meets Metabolomics: From Experiment to Systems Biology 2012, Springer. K. Suhre (Ed.).
9. Adamski J. Genome-wide association studies with metabolomics. Genome Med 2012, 4:34.
10. Suhre K., Gieger C. Genetic variation in metabolic phenotypes: study designs and applications. Nat Rev Genet 2012, 13:759-769.
11. Visscher P.M., Brown M.A., McCarthy M.I., Yang J. Five years of GWAS discovery. Am J Hum Genet 2012, 90:7-24.
12. Malet-Martino M., Holzgrabe U. NMR techniques in biomedical and pharmaceutical analysis. J Pharm Biomed Anal 2011, 55:1-15.
13. Griffiths W.J., Koal T., Wang Y., Kohl M., Enot D.P., Deigner H.P. Targeted metabolomics for biomarker discovery. Angew Chem Int Ed Engl 2010, 49:5426-5445.
14. Sreekumar A., Poisson L.M., Rajendiran T.M., Khan A.P., Cao Q., Yu J., Laxman B., Mehra R., Lonigro R.J., Li Y., et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009, 457:910-914.
15. Gieger C., Geistlinger L., Altmaier E., Hrabe de Angelis M., Kronenberg F., Meitinger T., Mewes H.W., Wichmann H.E., Weinberger K.M., Adamski J., et al. Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet 2008, 4:e1000282.
16. Shackleton C Clinical steroid mass spectrometry: a 45-year history culminating in HPLC-MS/MS becoming an essential tool for patient diagnosis. J Steroid Biochem Mol Biol 2010, 121:481-490.
17. Psychogios N., Hau D.D., Peng J., Guo A.C., Mandal R., Bouatra S., Sinelnikov I., Krishnamurthy R., Eisner R., Gautam B., et al. The human serum metabolome. PLoS ONE 2011, 6:e16957.
18. Dunn W.B., Broadhurst D., Begley P., Zelena E., Francis-McIntyre S., Anderson N., Brown M., Knowles J.D., Halsall A., Haselden J.N., et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc 2011, 6:1060-1083.
19. Wishart D.S., Knox C., Guo A.C., Eisner R., Young N., Gautam B., Hau D.D., Psychogios N., Dong E., Bouatra S., et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 2009, 37:D603-D610.
20. Skogerson K., Wohlgemuth G., Barupal D.K., Fiehn O. The volatile compound BinBase mass spectral database. BMC Bioinform 2011, 12:321.
21. Illig T., Gieger C., Zhai G., Romisch-Margl W., Wang-Sattler R., Prehn C., Altmaier E., Kastenmuller G., Kato B.S., Mewes H.W., et al. A genome-wide perspective of genetic variation in human metabolism. Nat Genet 2010, 42:137-141.
22. Giavalisco P., Kohl K., Hummel J., Seiwert B., Willmitzer L. 13C isotope-labeled metabolomes allowing for improved compound annotation and relative quantification in liquid chromatography-mass spectrometry-based metabolomic research. Anal Chem 2009, 81:6546-6551.
23. Xu Y., Heilier J.F., Madalinski G., Genin E., Ezan E., Tabet J.C., Junot C. Evaluation of accurate mass and relative isotopic abundance measurements in the LTQ-orbitrap mass spectrometer for further metabolomics database building. Anal Chem 2010, 82:5490-5501.
24. Griffin J.L., Atherton H., Shockcor J., Atzori L. Metabolomics as a tool for cardiac research. Nat Rev Cardiol 2011, 8:630-643.
25. 1H nuclear magnetic resonance spectroscopy metabolite identification in white wines from a sensory study investigating wine body. J Agric Food Chem 2009, 57:6899-6907.
26. Leon C., Rodriguez-Meizoso I., Lucio M., Garcia-Canas V., Ibanez E., Schmitt-Kopplin P., Cifuentes A. Metabolomics of transgenic maize combining Fourier transform-ion cyclotron resonance-mass spectrometry, capillary electrophoresis-mass spectrometry and pressurized liquid extraction. J Chromatogr A 2009, 1216:7314-7323.
27. Baumgarner B.L., Cooper B.R. Evaluation of a tandem gas chromatography/time-of-flight mass spectrometry metabolomics platform as a single method to investigate the effect of starvation on whole-animal metabolism in rainbow trout (Oncorhynchus mykiss). J Exp Biol 2012, 215:1627-1632.
28. Holle R., Happich M., Lowel H., Wichmann H.E. KORA-a research platform for population based health research. Gesundheitswesen 2005, 67(Suppl 1):S19-S25.
29. Suhre K., Meisinger C., Doring A., Altmaier E., Belcredi P., Gieger C., Chang D., Milburn M.V., Gall W.E., Weinberger K.M., et al. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS ONE 2010, 5:e13953.
30. Nicholson G., Rantalainen M., Li J.V., Maher A.D., Malmodin D., Ahmadi K.R., Faber J.H., Barrett A., Min J.L., Rayner N.W., et al. A genome-wide metabolic QTL analysis in Europeans implicates two loci shaped by recent positive selection. PLoS Genet 2011, 7:e1002270.
31. Hicks A.A., Pramstaller P.P., Johansson A., Vitart V., Rudan I., Ugocsai P., Aulchenko Y., Franklin C.S., Liebisch G., Erdmann J., et al. Genetic determinants of circulating sphingolipid concentrations in European populations. PLoS Genet 2009, 5:e1000672.
32. Tanaka T., Shen J., Abecasis G.R., Kisialiou A., Ordovas J.M., Guralnik J.M., Singleton A., Bandinelli S., Cherubini A., Arnett D., et al. Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study. PLoS Genet 2009, 5:e1000338.
33. Suhre K., Shin S.Y., Petersen A.K., Mohney R.P., Meredith D., Wagele B., Altmaier E., Deloukas P., Erdmann J., Grundberg E., et al. Human metabolic individuality in biomedical and pharmaceutical research. Nature 2011, 477:54-60.
34. Kettunen J., Tukiainen T., Sarin A.P., Ortega-Alonso A., Tikkanen E., Lyytikainen L.P., Kangas A.J., Soininen P., Wurtz P., Silander K., et al. Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet 2012, 44:269-276.
35. Demirkan A., van Duijn C.M., Ugocsai P., Isaacs A., Pramstaller P.P., Liebisch G., Wilson J.F., Johansson A., Rudan I., Aulchenko Y.S., et al. Genome-wide association study identifies novel loci associated with circulating phospho- and sphingolipid concentrations. PLoS Genet 2012, 8:e1002490.
36. Suhre K., Wallaschofski H., Raffler J., Friedrich N., Haring R., Michael K., Wasner C., Krebs A., Kronenberg F., Chang D., et al. A genome-wide association study of metabolic traits in human urine. Nat Genet 2011, 43:565-569.
37. Paul Lee W.N., Wahjudi P.N., Xu J., Go V.L. Tracer-based metabolomics: concepts and practices. Clin Biochem 2010, 43:1269-1277.
38. Zumbuehl A. Nonnatural pholpholipids: probing nature's modular platform. Chimia 2009, 63:63-65.
39. Honour J.W. Gas chromatography-mass spectrometry. Methods Mol Biol 2006, 324:53-74.
40. Gaspar A., Englmann M., Fekete A., Harir M., Schmitt-Kopplin P. Trends in CE-MS 2005-2006. Electrophoresis 2008, 29:66-79.
41. Petersen A.K., Krumsiek J., Wagele B., Theis F.J., Wichmann H.E., Gieger C., Suhre K. On the hypothesis-free testing of metabolite ratios in genome-wide and metabolome-wide association studies. BMC Bioinform 2012, 13:120.
42. Kathiresan S., Melander O., Guiducci C., Surti A., Burtt N.P., Rieder M.J., Cooper G.M., Roos C., Voight B.F., Havulinna A.S., et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nature Genet 2008, 40:189-197.
43. Willer C.J., Sanna S., Jackson A.U., Scuteri A., Bonnycastle L.L., Clarke R., Heath S.C., Timpson N.J., Najjar S.S., Stringham H.M., et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 2008, 40:161-169.
44. Kathiresan S., Willer C.J., Peloso G.M., Demissie S., Musunuru K., Schadt E.E., Kaplan L., Bennett D., Li Y., Tanaka T., et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nature Genet 2009, 41:56-65.
45. Franke A., McGovern D.P., Barrett J.C., Wang K., Radford-Smith G.L., Ahmad T., Lees C.W., Balschun T., Lee J., Roberts R., et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010, 42:1118-1125.
46. Morales E., Bustamante M., Gonzalez J.R., Guxens M., Torrent M., Mendez M., Garcia-Esteban R., Julvez J., Forns J., Vrijheid M., et al. Genetic variants of the FADS gene cluster and ELOVL gene family, colostrums LC-PUFA levels, breastfeeding, and child cognition. PLoS ONE 2011, 6:e17181.
47. Brookes K.J., Chen W., Xu X., Taylor E., Asherson P. Association of fatty acid desaturase genes with attention-deficit/hyperactivity disorder. Biol Psychiatry 2006, 60:1053-1061.
48. Levant B., Zarcone T.J., Fowler S.C. Developmental effects of dietary n-3 fatty acids on activity and response to novelty. Physiol Behav 2010, 101:176-183.
49. Dumont J., Huybrechts I., Spinneker A., Gottrand F., Grammatikaki E., Bevilacqua N., Vyncke K., Widhalm K., Kafatos A., Molnar D., et al. FADS1 genetic variability interacts with dietary alpha-linolenic acid intake to affect serum non-HDL-cholesterol concentrations in European adolescents. J Nutr 2011, 141:1247-1253.
50. Lu Y., Feskens E.J., Dolle M.E., Imholz S., Verschuren W.M., Muller M., Boer J.M. Dietary n-3 and n-6 polyunsaturated fatty acid intake interacts with FADS1 genetic variation to affect total and HDL-cholesterol concentrations in the Doetinchem Cohort Study. Am J Clin Nutr 2010, 92:258-265.